Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference

NEXT STORY
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
PREV STORY
Cullinan Management, Inc. Announces Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Amarin Supports Trial to Investigate the Effects of VASCEPA® (icosapent ethyl) in the Treatment of COVID-19

author_avatar
NASDAQ Market News

NANOBIOTIX presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical Oncology Gastrointestinal Annual Meeting

 NANOBIOTIX PRESENTS FIRST PROMISING DATA FROM PHASE I/II LIVER CANCERS TRIAL OF NBTXR3 AT THE ...

author_avatar
NASDAQ Market News

Cytori Reports First Quarter 2017 Business and Financial Results

SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the ...

author_avatar
NASDAQ Market News